Lyell Immunopharma, Inc. (NASDAQ:LYEL) IPO
IPO
Priced at US$17.00 a share on Jun 16, 2021.
- Price
- US$17.00 a share
- Shares offered
- 25,000,000 shares of common stock
- Offering size
- US$425 million
- Underwriters' option
- Up to 3,750,000 more shares
- Underwriters
- Goldman Sachs & Co. LLC, BofA Securities, J.P. Morgan, Morgan Stanley · In the order on the cover
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Apr 12, 2021 |
| Filed publicly | May 25, 2021 |
| Amended once | Jun 9, 2021 |
| Shares registered with an exchange | Jun 14, 2021 |
| Declared effective by the SEC | Jun 16, 2021 |
| Final prospectus, with the price | Jun 21, 2021 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Jun 21, 2021 |
| EFFECT · Notice that a registration is effective | Jun 16, 2021 |
| CERT · Exchange's certificate of listing | Jun 16, 2021 |
| 8-A12B · Registration of shares for listing on an exchange | Jun 14, 2021 |
| CORRESP · Letter to the SEC | Jun 14, 2021 |
| CORRESP · Letter to the SEC | Jun 14, 2021 |
| S-1/A · Registration statement, amended | Jun 9, 2021 |
| CORRESP · Letter to the SEC | Jun 7, 2021 |
| UPLOAD · Letter from the SEC | Jun 4, 2021 |
| CORRESP · Letter to the SEC | Jun 1, 2021 |
| CORRESP · Letter to the SEC | May 28, 2021 |
| UPLOAD · Letter from the SEC | May 25, 2021 |
| S-1 · Registration statement | May 25, 2021 |
| DRSLTR · Letter to the SEC with a draft | May 12, 2021 |
| DRS/A · Draft registration statement, amended | May 12, 2021 |
| UPLOAD · Letter from the SEC | May 7, 2021 |
| DRS · Draft registration statement | Apr 12, 2021 |
From the cover of the final prospectus (424B4) filed Jun 21, 2021